Article · 29 Dec 2025
Conference abstractPublished 27 Oct 2014
Design and synthesis of some novel antibacterial agents targeting Gyrase B and Par E
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The remarkable ability of bacteria to develop resistance to antibacterial agents is the reason for the continued need to search for new antibacterial targets and develop novel antimicrobial agents. A drug target is likely to develop resistance if it cannot easily tolerate change and maintain function. Many drug targets are enzymes. Because these enzymes perform highly constrained and crucial chemical reactions, they can represent resilient targets that are less susceptible to drug resistance. The use of high-resolution structures and evolutionary constraints aids the design of robust inhibitors. DNA gyrase (GyrA and GyrB) and topoisomerase IV (ParC and ParE) are the two type II topoisomerases present in bacteria and are attractive targets for antibacterial drug discovery. The associated subunits responsible for supplying the energy necessary for catalytic turnover/resetting of the enzymes via ATP hydrolysis are GyrB (gyrase) and ParE (topoIV), respectively. The ATP binding sites in these subunits have been less successfully exploited as antibacterial targets with the exception of the natural product coumarins, e.g., novobiocin and cyclothialadines. By choosing resilient targets and designing robust inhibitors the Institute for Drug Resistance (IDR) proposes to focus on drug resistance in drug design strategies, and develop a new generation of moreeffective therapeutics.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Janarthanan T”
- BylineArticles whose byline prints “Md.Afzal Azam”
